about
"You Shall Not Pass"-tight junctions of the blood brain barrierIntegrity of Narrow Epithelial Tubes in the C. elegans Excretory System Requires a Transient Luminal MatrixStructural Determinants for Binding of Sorting Nexin 17 (SNX17) to the Cytoplasmic Adaptor Protein Krev Interaction Trapped 1 (KRIT1)Structural analysis of the KRIT1 ankyrin repeat and FERM domains reveals a conformationally stable ARD-FERM interfaceCCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formationStructural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutationsRHO binding to FAM65A regulates Golgi reorientation during cell migrationCombined HMG-COA reductase and prenylation inhibition in treatment of CCM.The pathobiology of vascular malformations: insights from human and model organism genetics.Genetics of cerebral cavernous malformations: current status and future prospectsDownregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma.Apicobasal polarity of brain endothelial cells.Nogo-B receptor deficiency causes cerebral vasculature defects during embryonic development in mice.Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.The Caenorhabditis elegans Excretory System: A Model for Tubulogenesis, Cell Fate Specification, and PlasticityA Novel CCM2 Gene Mutation Associated with Familial Cerebral Cavernous MalformationIntroduction to cerebral cavernous malformation: a brief review.Ccm3, a gene associated with cerebral cavernous malformations, is required for neuronal migration.PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations.Endothelial fluid shear stress sensing in vascular health and disease.Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies.Time to make the doughnuts: Building and shaping seamless tubes.Genome-Wide Sequencing Reveals MicroRNAs Downregulated in Cerebral Cavernous Malformations.Update on Novel CCM Gene Mutations in Patients with Cerebral Cavernous Malformations.The molecular basis of endothelial cell plasticity.EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation.CCM proteins control endothelial β1 integrin dependent response to shear stress.Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences β1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus.A Novel MGC4607/CCM2 Gene Mutation Associated with Cerebral Spinal and Cutaneous Cavernous Angiomas.Dysregulated exocytosis of angiopoietin-2 drives cerebral cavernous malformation.PHACE syndrome is associated with intracranial cavernous malformations.Genetic Screening of Pediatric Cavernous Malformations.
P2860
Q21129349-449D3AE5-F8C4-4D53-8FCF-E3C86845DEF0Q27308141-5A92F06F-CD8C-4E50-AFC0-29700F1A4619Q27684808-9D2463A7-8BDD-4857-946E-744D50031A6FQ28607249-6EFBA892-3B07-4885-84C9-D4F07877E321Q28650415-019F6FEF-4B6F-46D5-A824-9E4FC1D716EBQ28650470-73C0CC8B-B8A0-4EF9-A534-60780FAF8986Q29147496-973FDEC8-6D58-4B85-88C4-CEDCD5A86959Q33737847-4D0CB271-DBD3-4115-80FE-8A4EF529DBD0Q34544980-2A6B9E21-C6CD-45FF-8327-BC2E50A63809Q35706117-B71015BC-45B9-469E-B7C0-2EFF685A84B2Q35816668-B440F2B0-9F79-4DAE-8DAE-C21C3A3507A1Q36595837-D66DC45E-C230-41DA-8CBD-8E1E379CD4E3Q36619170-09E8E9A9-E68B-430E-A1C9-F97760427201Q36705891-551D0797-BC38-41DB-B068-CF4872D6B129Q36875639-5BB35B95-F21A-4D4C-9AEA-6738751C392FQ37270784-2B926D56-5ACC-43EB-A35C-849DA46F1604Q37351147-3E19CDAA-2690-45FA-A48A-31EE70565D02Q37618688-941EDE32-B183-4025-838A-A7DB992EB49FQ38268858-29DCCF75-3F35-4347-AF20-970495F663B9Q38630594-181DC6B2-F097-418A-ABCC-523192A38266Q38824364-737E1E1D-5FB5-49BA-9894-FAC5C4043123Q38834183-EAD974BE-B292-47FD-B09E-95B77496DC74Q38970560-49DD1B05-9D4E-4A1B-A553-A1B74FF7FC96Q39079343-D667E266-0B6D-4CA1-B4CE-31484D8F9A3CQ39127982-EB9EC025-C576-4033-BC92-57302BE8C100Q41520269-F3C05805-0C3A-4B0B-9804-E4AAAF751E4AQ42615679-0CBD08F8-37D3-466B-92F6-D40E03A090B5Q48127718-852F2F25-9977-49BC-8BCF-13E8EE1F156DQ48231967-3E0490B7-975A-4442-9442-21E3BDF623E6Q48526422-BDC1ABFB-5046-4ECE-A5EA-B4A399A3CDFBQ50903947-2AA62BDE-7F5C-4129-B899-2DDF16CBA691Q51550191-A0CF3A41-FD78-439B-BFDE-55CD22BF0EBB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cerebral cavernous malformation proteins at a glance.
@en
Cerebral cavernous malformation proteins at a glance.
@nl
type
label
Cerebral cavernous malformation proteins at a glance.
@en
Cerebral cavernous malformation proteins at a glance.
@nl
prefLabel
Cerebral cavernous malformation proteins at a glance.
@en
Cerebral cavernous malformation proteins at a glance.
@nl
P2860
P356
P1476
Cerebral cavernous malformation proteins at a glance
@en
P2093
Kyle M Draheim
Titus J Boggon
P2860
P304
P356
10.1242/JCS.138388
P407
P577
2014-01-30T00:00:00Z